You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogen Receptor Modulators

Showing 1 - 25 of 9,068
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Schizophrenia, Schizoaffective Disorder Trial in Melbourne (Raloxifene HCl, Placebo)

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Raloxifene hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Monash Alfred Psychiatry Research Centre
Jan 6, 2020

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Melbourne (Raloxifene Hydrochloride, Placebo)

Unknown status
  • Schizophrenia
  • +2 more
  • Raloxifene Hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Alfred Hospital
Jan 6, 2020

MS Patients Treated With Sphingosine-1-phosphate Receptor

Recruiting
  • Multiple Sclerosis
  • S1PR analysis on immune cells
  • Bern, Switzerland
    Neurology department
Apr 12, 2023

Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

Recruiting
  • Alcohol Use Disorder
  • Columbus, Ohio
    The Ohio State University
Dec 11, 2022

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Recruiting
  • Breast Cancer
  • +2 more
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 12, 2022

    Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

    Not yet recruiting
    • Low Grade Serous Ovarian Carcinoma
    • Adult Type Granulosa Cell Tumor
    • Gent, Oost-Vlaanderen, Belgium
    • +2 more
    May 12, 2023

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Schizophrenia Trial in Shanghai (Raloxifene Hydrochloride, Placebo)

    Completed
    • Schizophrenia
    • Raloxifene Hydrochloride
    • Placebo
    • Shanghai, Minhang, China
      CHINA
    Sep 4, 2019

    Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

    Not yet recruiting
    • Breast Cancer
    • Brain Metastases
    • Brain Imaging with 18F-FES
    • New York, New York
      New York-Presbyterian/Weill Cornell Medical Center
    Oct 2, 2023

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • ARV-471 (PF-07850327)
    • +2 more
    • Orange City, Florida
      Mid Florida Hematology and Oncology Center
    Jun 8, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

    Recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Breast Cancer
    • Houston, Texas
      Houston Methodist Cancer Center
    Nov 18, 2022

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Metastatic Breast Cancer Trial (Elacestrant)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2022

    Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • Low Grade Serous Adenocarcinoma of Ovary
    • Letrozole tablets
    • carboplatin AUC 5 and paclitaxel 175 mg/m2
    • Brescia, BS, Italy
    • +1 more
    Oct 26, 2022

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • AND019 PO QD
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 19, 2022

    Uterine Cancer Trial in Philadelphia (18F-Fluoroestradiol)

    Not yet recruiting
    • Uterine Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 21, 2023